Biology

We’re changing that.
Introducing our first-in-class disease activity blood test, which provides real-time assessment of the underlying biology, pathways, mechanisms, and cell types involved in a patient’s MS.

Our multi-protein assay is a dynamic measure of immune modulation, inflammation, myelin biology, and neuroaxonal integrity validated through an extensive multiple sclerosis research and development process and clinical study.

Finally, a solution to quantitatively measure subclinical multiple sclerosis disease activity and detect relapses that can be used to identify suboptimal responses to current interventions. This is only the beginning—we’re at work
on other serum-based tests to bring additional insights to light.